- Details
- In an area where we have multiple options for treatment and we continue to have more data that helps to guide us, Evan Yu joins Alicia Morgans to speak about systemic treatment sequencing in the metastatic castration-resistant prostate cancer (mCRPC) setting and his approach to moving a patient through the different phases of their treatment. Biographies: Evan Yu, MD, Medical oncologist, treats pr...
|
- Details
- Recorded Date: April 29, 2020 Matthew Galsky joins Alicia Morgans to provide an update on how COVID-19 has affected his clinical practice and the treatment of bladder cancer patients at Mount Sinai hospital and the Tisch Cancer Institute. With the increase of patients being concerned about traveling and the risk of exposure, Dr. Galsky explains how they have ramped up their telehealth capabilities...
|
- Details
- Recorded Date: April 24, 2020 Joining Alicia Morgans is Lorelei Mucci and Philip Kantoff discussing a recently published article that addresses some of the potential overlaps between TMPRSS2 and COVID-19. Biographies: Philip Kantoff, MD., is the Chair, Department of Medicine; The George J. Bosl Chair Memorial Sloan Kettering Cancer Center. He is a board-certified medical oncologist and researcher...
|
- Details
- Srikala (Kala) Sridhar joins Alicia Morgans to discuss the recent developments in urothelial cancer of the bladder and upper tract. The two discuss controversial issues in urothelial carcinoma from the American Joint Committee on Cancer (AJCC) staging to chemotherapy in upper tract disease, to bladder sparing recent clinical trial findings, and the impact of those trials on clinical practice treat...
|
- Details
- (Length of Interview: 2 min) Andy Schwartz, a prostate cancer advocate, and survivor answers a series of questions and explains the importance of seeking information to better prepare yourself for prostate cancer treatment. 1. How did you go about making your treatment decision? 2. Did you feel that you had an adequate understanding of all the pros and cons of each treatment that was available to...
|
- Details
- Matthew Smith shares his thoughts on the importance of bone health in the prostate cancer patient population. Osteoporotic or fragility fractures are common due to the age of the patient and long-term androgen deprivation therapy. Fractures have a great impact on patient mortality, mobility, independence, and overall quality of life. Dr. Smith addresses questions regarding bone density measurement...
|
- Details
- Recorded Date: April 26, 2020 In this conversation, Alicia Morgans speaks with Charles Drake, Professor of Medicine and Urology, and the head of GU Oncology at Columbia New York-Presbyterian in New York City about how he and his team have been influenced by COVID-19 in New York City. Biographies: Charles G. Drake, MD, Ph.D., Department of Medicine, Division of Hematology/Oncology, Co-Director, Can...
|
|
|
- Details
- Recorded Date: April 24, 2020 William Oh joins Alicia Morgans providing an update to a previously recorded conversation from the center of the COVID-19 pandemic in New York City. As the city begins to pass the peak of the initial wave of the virus, Dr. Oh looks into the upcoming weeks and months as New York begins to loosen its restrictions. With many patients needing to be seen, the expectation i...
|
- Details
- Recorded Date: April 24, 2020 Jamie Landman and Monty Pal host a panel of experts to help sort through the information available online regarding kidney-associated complications with COVID-19. Together, Dena Battle, Kam Kalantar-Zadeh, Connie Rhee, and Michael Staehler address patients' concerns regarding kidney function and COVID-19. Biographies: Kamyar Kalantar-Zadeh, MD, MPH, Ph.D., Chief and P...
|
